In March 2025, the company introduced new designs for the direct-to-client giving of its Wegovy weight loss drug. The company founded a brand new pharmacy, referred to as NovoCare, which would charge prospects $499 per month for usage of the drug, lower than 50 percent the price of the drug through other pharmaceutical distribution networks.[fifty